Enliven Therapeutics, Inc. (ELVN) Earnings
Enliven Therapeutics, Inc. is expected to report next earnings on November 11, 2026 (in NaN days), with a consensus EPS estimate of $-0.43. ELVN has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise -0.4% over the last four).
Next earnings
Nov 11, 2026in NaN days
EPS est $-0.43 · Revenue est —
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -0.4% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 5, 2026 | $-0.39 | $-0.49 | -26.6% | — | — |
| May 7, 2026 | $-0.44 | $-0.38 | +13.6% | — | — |
| Mar 3, 2026 | $-0.42 | $-0.48 | -14.3% | — | — |
| Nov 12, 2025 | $-0.43 | $-0.32 | +25.6% | — | — |
| Aug 13, 2025 | $-0.53 | $-0.49 | +7.5% | — | — |
| May 14, 2025 | $-0.51 | $-0.57 | -11.8% | — | — |
| Mar 13, 2025 | $-0.53 | $-0.46 | +13.2% | — | — |
| Mar 14, 2024 | $-0.56 | $-0.47 | +16.1% | $440000 | — |
| Nov 9, 2023 | $-0.49 | $-0.51 | -4.1% | — | — |
| Aug 10, 2023 | $-0.40 | $-0.41 | -2.5% | — | — |
| May 11, 2023 | $-0.67 | $-0.80 | -19.4% | — | — |
| Feb 10, 2023 | $-0.79 | $1.23 | +256.5% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.